Bamipine: Difference between revisions

	WikiDoc Resources for Bamipine
Articles
Most recent articles on Bamipine Most cited articles on Bamipine Review articles on Bamipine Articles on Bamipine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Bamipine Images of Bamipine Photos of Bamipine Podcasts & MP3s on Bamipine Videos on Bamipine
Evidence Based Medicine
Cochrane Collaboration on Bamipine Bandolier on Bamipine TRIP on Bamipine
Clinical Trials
Ongoing Trials on Bamipine at Clinical Trials.gov Trial results on Bamipine Clinical Trials on Bamipine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Bamipine NICE Guidance on Bamipine NHS PRODIGY Guidance FDA on Bamipine CDC on Bamipine
Books
Books on Bamipine
News
Bamipine in the news Be alerted to news on Bamipine News trends on Bamipine
Commentary
Blogs on Bamipine
Definitions
Definitions of Bamipine
Patient Resources / Community
Patient resources on Bamipine Discussion groups on Bamipine Patient Handouts on Bamipine Directions to Hospitals Treating Bamipine Risk calculators and risk factors for Bamipine
Healthcare Provider Resources
Symptoms of Bamipine Causes & Risk Factors for Bamipine Diagnostic studies for Bamipine Treatment of Bamipine
Continuing Medical Education (CME)
CME Programs on Bamipine
International
Bamipine en Espanol Bamipine en Francais
Business
Bamipine in the Marketplace Patents on Bamipine
Experimental / Informatics
List of terms related to Bamipine

Bamipine
	File:Bamipine.svg
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral, topical
ATC code	D04AA15 (WHO) R06AX01 (WHO);
Identifiers
	IUPAC name N-benzyl-1-methyl-N-phenyl-piperidin-4-amine;
CAS Number	4945-47-5 ;
PubChem CID	72075;
ChemSpider	65061 ;
UNII	Y6BHZ28O92;
KEGG	D07197 ;
ChEMBL	ChEMBL520400 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C19H24N2
Molar mass	280.407 g/mol
3D model (JSmol)	Interactive image;
	SMILES N(c1ccccc1)(Cc2ccccc2)C3CCN(C)CC3;
	InChI InChI=1S/C19H24N2/c1-20-14-12-19(13-15-20)21(18-10-6-3-7-11-18)16-17-8-4-2-5-9-17/h2-11,19H,12-16H2,1H3 ; Key:VZSXTYKGYWISGQ-UHFFFAOYSA-N ;
(verify)

← Older edit Newer edit →

VisualWikitext

Revision as of 18:54, 6 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Bamipine is an antihistamine with anticholinergic properties used as an antipruritic.^[1]

References

↑ [1], M Pairet, MP Pieper, CJM Meade, "Pharmaceutical compositions containing tiotropium salts and antihistamines and their use", published 2001

Template:Antipruritics

[1] [1], M Pairet, MP Pieper, CJM Meade, "Pharmaceutical compositions containing tiotropium salts and antihistamines and their use", published 2001

[1]

@@ Line 1: / Line 1: @@
-{{drugbox
+{{Drugbox
-| IUPAC_name        = ''N''-benzyl-1-methyl-''N''-phenyl-piperidin-4-amine
+| verifiedrevid = 437205596
-| image             =
+| IUPAC_name = ''N''-benzyl-1-methyl-''N''-phenyl-piperidin-4-amine
-| CAS_number        = 4945-47-5
+| image = Bamipine.svg
-| ATC_prefix        = D04
-| ATC_suffix        = AA15
+<!--Clinical data-->
-| ATC_supplemental  = {{ATC|R06|AX01}}
+| tradename =
-| PubChem           = 72075
+| Drugs.com = {{drugs.com|international|bamipine}}
-| DrugBank          =
-| C = 19 | H = 24 | N = 2
-| molecular_weight  = 280.407 g/mol
-| bioavailability   =
-| protein_bound     =
-| metabolism        =
-| elimination_half-life =
-| excretion         =
-| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
-| pregnancy_US      =  <!-- A / B            / C / D / X -->
-| pregnancy_category=
-| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
-| legal_CA          =  <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
-| legal_UK          =  <!-- GSL         / P       / POM / CD / Class A, B, C -->
-| legal_US          =  <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
-| legal_status      =
 | routes_of_administration = Oral, topical
+<!--Identifiers-->
+| CAS_number_Ref = {{cascite|correct|??}}
+| CAS_number = 4945-47-5
+| ATC_prefix = D04
+| ATC_suffix = AA15
+| ATC_supplemental =  {{ATC|R06|AX01}}
+| PubChem = 72075
+| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
+| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
+| ChemSpiderID = 65061
+| UNII_Ref = {{fdacite|correct|FDA}}
+| UNII = Y6BHZ28O92
+| KEGG_Ref = {{keggcite|correct|kegg}}
+| KEGG = D07197
+| ChEMBL_Ref = {{ebicite|correct|EBI}}
+| ChEMBL = 520400
+<!--Chemical data-->
+| C=19 | H=24 | N=2
+| molecular_weight = 280.407 g/mol
+| smiles = N(c1ccccc1)(Cc2ccccc2)C3CCN(C)CC3
+| InChI = 1/C19H24N2/c1-20-14-12-19(13-15-20)21(18-10-6-3-7-11-18)16-17-8-4-2-5-9-17/h2-11,19H,12-16H2,1H3
+| InChIKey = VZSXTYKGYWISGQ-UHFFFAOYAD
+| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
+| StdInChI = 1S/C19H24N2/c1-20-14-12-19(13-15-20)21(18-10-6-3-7-11-18)16-17-8-4-2-5-9-17/h2-11,19H,12-16H2,1H3
+| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
+| StdInChIKey = VZSXTYKGYWISGQ-UHFFFAOYSA-N
 }}
 __NOTOC__
@@ Line 30: / Line 42: @@
 ==Overview==
-'''Bamipine''' is an [[antihistamine]] employed as an [[antipruritic]].
+'''Bamipine''' is an [[antihistamine]] with [[anticholinergic]] properties used as an [[antipruritic]].<ref>{{Cite patent |title = Pharmaceutical compositions containing tiotropium salts and antihistamines and their use |inventor = M Pairet, MP Pieper, CJM Meade |pubdate = 2001 |url = http://www.google.ca/patents?hl=en&lr=&vid=USPATAPP10007182&id=b0eWAAAAEBAJ&oi=fnd&dq=Bamipine+antihistamine+anticholinergic&printsec=abstract#v=onepage&q=Bamipine%20antihistamine%20anticholinergic&f=false}}</ref>
+== References ==
+{{Reflist|2}}
 {{Antipruritics}}
+{{Antihistamines}}
 [[Category:Drug]]
+[[Category:H1 receptor antagonists]]
+[[Category:Piperidines]]

v t e Antihistamines (R06)
Aminoalkyl ethers	Bromazine/Bromodiphenhydramine • Carbinoxamine • Clemastine • Chlorphenoxamine • Diphenylpyraline • Diphenhydramine • Doxylamine • Orphenadrine • Phenyltoloxamine
Substituted alkylamines	Brompheniramine • Chlorphenamine • Dexbrompheniramine • Dexchlorpheniramine • Dimetindene • Pheniramine • Talastine
Substituted ethylenediamines	Chloropyramine • Histapyrrodine • Mepyramine • Methapyrilene • Tripelennamine (Pyribenzamine)
Phenothiazine derivatives	Alimemazine • Hydroxyethylpromethazine • Isothipendyl • Mequitazine • Methdilazine • Oxomemazine • Promethazine
Piperazine derivatives	Buclizine • Cetirizine • Chlorcyclizine • Cinnarizine • Cyclizine • Hydroxyzine • Levocetirizine • Meclizine • Niaprazine • Oxatomide
Others for systemic use	Antazoline • Azatadine • Bamipine • Cyproheptadine • Deptropine • Dimebon • Ebastine • Epinastine • Ketotifen • Mebhydrolin • Mizolastine • Phenindamine • Pimethixene • Pyrrobutamine • Rupatadine • Triprolidine • selective (Acrivastine • Astemizole • Azelastine • Desloratadine • Fexofenadine • Loratadine • Terfenadine)
For topical use	Bamipine • Chloropyramine • Chlorphenoxamine • Clemastine • Dimetindene • Diphenhydramine • Isothipendyl • Mepyramine • Promethazine • Thenalidine
Antiallergic agents excluding corticosteroids	Antazoline • Azelastine
Other antiallergics	Emedastine • Epinastine • Ketotifen • Montelukast • Olopatadine

Bamipine: Difference between revisions

Revision as of 18:54, 6 April 2015

Overview

References

Navigation menu

Search